BioSpace News Archive

FSD Pharma Inc. announced that its wholly-owned subsidiary, FV Pharma Inc., a licensed cannabis producer under the Cannabis Act, has received its Standard Processing License.

International medical imaging IT and cybersecurity company Sectra has received an order from Radboud University Medical Center in the Netherlands for its IT solution for digital pathology.

Xellia Pharmaceuticals announced it has received U.S. Food and Drug Administration (FDA) approval for Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag in the United States market.

Activz Global, LLC is proud to announce the appointment of Vice Admiral Mathias W. Winter to the company’s Board of Advisers.

LAIX Inc. announced that it will report its fourth quarter and full year 2018 unaudited financial results on Wednesday, February 27, 2019, before the open of the U.S. markets.

Five cancer centers in the UK have placed new orders on the treatment planning system RayStation from RaySearch. The orders strengthen RaySearch’s position in the UK market further.

Fire & Flower Holdings Corp. is pleased to announce that its subsidiary, Fire & Flower Inc., has entered into agreements with two of the initial 25 applicants that have been selected by the Alcohol and Gaming Commission of Ontario to apply for cannabis Retail Operator Licences in the East Region of Ontario.

Global Cord Blood Corporation announced that it plans to release its unaudited financial results for the third quarter and first nine months of fiscal year 2019 on Monday, February 25, 2019, after the market close.

Precision medicine platform assists in finding markers for personalized patient care and improves drug development of neurodegenerative diseases

Apexigen, Inc. announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences